The pathogenesis of atherosclerosis: a perspective for the 1990s
暂无分享,去创建一个
[1] R. Virchow,et al. Gesammelte Abhandlungen zur wissenschaftlichen Medicin , 1856 .
[2] R. Ross,et al. Atherosclerosis and the Arterial Smooth Muscle Cell , 1973 .
[3] R. Ross,et al. Hyperlipidemia and atherosclerosis. , 1976, Science.
[4] R. Ross,et al. The pathogenesis of atherosclerosis (first of two parts). , 1976, The New England journal of medicine.
[5] M. Brown,et al. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[6] C. Minick,et al. Atheroarteriosclerosis induced by infection with a herpesvirus. , 1979, The American journal of pathology.
[7] R. Ross. George Lyman Duff Memorial Lecture. Atherosclerosis: a problem of the biology of arterial wall cells and their interactions with blood components. , 1981, Arteriosclerosis.
[8] R. Furchgott. Role of endothelium in responses of vascular smooth muscle. , 1983, Circulation research.
[9] H. Mcgill,et al. George Lyman Duff memorial lecture. Persistent problems in the pathogenesis of atherosclerosis. , 1984, Arteriosclerosis.
[10] M J Davies,et al. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. , 1984, The New England journal of medicine.
[11] R. Ross,et al. Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery. , 1984, The American journal of pathology.
[12] R. Ross,et al. Studies of Hypercholesterolemia in the Nonhuman Primate: I. Changes that Lead to Fatty Streak Formation , 1984, Arteriosclerosis.
[13] R. Ross,et al. Studies of Hypercholesterolemia in the Nonhuman Primate: II. Fatty Streak Conversion to Fibrous Plaque , 1984, Arteriosclerosis.
[14] L. Old,et al. Tumor necrosis factor (TNF). , 1985, Science.
[15] C. Dalsgaard,et al. Stimulation of connective tissue cell growth by substance P and substance K , 1985, Nature.
[16] D. N. Kim,et al. Cell Population Kinetics in Atherogenesis Cell Births and Losses in Intimal Cell Mass‐Derived Lesions in the Abdominal Aorta of Swine a , 1985, Annals of the New York Academy of Sciences.
[17] D. Morel,et al. Monocytes and Neutrophils Oxidize Low Density Lipoprotein Making It Cytotoxic , 1985, Journal of leukocyte biology.
[18] R. Gerrity,et al. Control of Monocyte Recruitment by Chemotactic Factor(s) in Lesion‐Prone Areas of Swine Aorta , 1985, Arteriosclerosis.
[19] E. Stanley. The macrophage colony-stimulating factor, CSF-1. , 1985, Methods in enzymology.
[20] R. Ross,et al. A significant part of macrophage-derived growth factor consists of at least two forms of PDGF , 1985, Cell.
[21] R. Ross. The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.
[22] A. Gown,et al. Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. , 1986, The American journal of pathology.
[23] S. Moncada,et al. Arachidonate metabolism in blood cells and the vessel wall. , 1986, Clinics in haematology.
[24] J. Nilsson. Growth factors and the pathogenesis of atherosclerosis. , 1986, Atherosclerosis.
[25] N. E. Owen. Effect of prostaglandin E1 on DNA synthesis in vascular smooth muscle cells. , 1986, The American journal of physiology.
[26] G. Bondjers,et al. Regional Accumulations of T Cells, Macrophages, and Smooth Muscle Cells in the Human Atherosclerotic Plaque , 1986, Arteriosclerosis.
[27] A. Gown,et al. Immunocytochemical analysis of cellular components in atherosclerotic lesions. Use of monoclonal antibodies with the Watanabe and fat-fed rabbit. , 1986, Arteriosclerosis.
[28] P. Libby,et al. Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. , 1986, The American journal of pathology.
[29] R. Ross,et al. The biology of platelet-derived growth factor , 1986, Cell.
[30] P. Davies. Vascular cell interactions with special reference to the pathogenesis of atherosclerosis. , 1986, Laboratory investigation; a journal of technical methods and pathology.
[31] T. Carew,et al. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[32] K. Hajjar,et al. Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cells , 1987, The Journal of experimental medicine.
[33] J. Thyberg,et al. Leukotrienes stimulate initiation of DNA synthesis in cultured arterial smooth muscle cells. , 1987, Journal of cell science.
[34] A. Gown,et al. Fatty streak expansion and maturation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. , 1987, Arteriosclerosis.
[35] M. Sporn,et al. Some recent advances in the chemistry and biology of transforming growth factor-beta , 1987, The Journal of cell biology.
[36] A. Gown,et al. Fatty streak initiation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. , 1987, Arteriosclerosis.
[37] N. Simionescu,et al. Prelesional events in atherogenesis. Colocalization of apolipoprotein B, unesterified cholesterol and extracellular phospholipid liposomes in the aorta of hyperlipidemic rabbit. , 1987, Atherosclerosis.
[38] A. Ooshima,et al. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[39] D. Steinberg,et al. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[40] C. Heldin,et al. Arterial smooth muscle cells express platelet-derived growth factor (PDGF) A chain mRNA, secrete a PDGF-like mitogen, and bind exogenous PDGF in a phenotype- and growth state-dependent manner , 1988, The Journal of cell biology.
[41] D. Ingber,et al. A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane. , 1988, The American journal of pathology.
[42] P. Libby,et al. Production of platelet-derived growth factor-like mitogen by smooth-muscle cells from human atheroma. , 1988, The New England journal of medicine.
[43] C. Heldin,et al. INDUCTION OF B-TYPE RECEPTORS FOR PLATELET-DERIVED GROWTH FACTOR IN VASCULAR INFLAMMATION: POSSIBLE IMPLICATIONS FOR DEVELOPMENT OF VASCULAR PROLIFERATIVE LESIONS , 1988, The Lancet.
[44] Julie H. Campbell,et al. Arterial smooth muscle. A multifunctional mesenchymal cell. , 1988, Archives of pathology & laboratory medicine.
[45] T. Barrett,et al. Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[46] Sadao Kimura,et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.
[47] J. Pepper,et al. Morphology of the endothelium over atherosclerotic plaques in human coronary arteries. , 1988, British heart journal.
[48] Kathleen M. Smith,et al. Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. , 1988, The Journal of clinical investigation.
[49] N. Morisaki,et al. Cell cycle-dependent inhibition of DNA synthesis by prostaglandin I2 in cultured rabbit aortic smooth muscle cells. , 1988, Atherosclerosis.
[50] R. Ross,et al. Two classes of PDGF receptor recognize different isoforms of PDGF. , 1988, Science.
[51] S. Dower,et al. Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. , 1989, Science.
[52] H. Shimokawa,et al. Impaired Endothelium‐Dependent Relaxation to Aggregating Platelets and Related Vasoactive: Substances in Porcine Coronary Arteries in Hypercholesterolemia and Atherosclerosis , 1989, Circulation research.
[53] G. King,et al. Insulin, insulin-like growth factor I and platelet-derived growth factor interact additively in the induction of the protooncogene c-myc and cellular proliferation in cultured bovine aortic smooth muscle cells. , 1989, Molecular endocrinology.
[54] D. Steinberg,et al. A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[55] J L Witztum,et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. , 1989, The Journal of clinical investigation.
[56] T. Maciag,et al. The heparin-binding (fibroblast) growth factor family of proteins. , 1989, Annual review of biochemistry.
[57] M. Reidy,et al. Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[58] Cotran Rs,et al. The Pathogenesis of Atherosclerosis: Atherogenesis and Inflammation , 1989 .
[59] H. Weiss,et al. Cell constitution and characteristics of human atherosclerotic plaques selectively removed by percutaneous atherectomy. , 1989, Atherosclerosis.
[60] P. Libby,et al. Cytokines as modulators of cell proliferation in fibrotic diseases. , 1989, The American review of respiratory disease.
[61] E. Edelman,et al. Biological and biochemical properties of fibroblast growth factors. Implications for the pathogenesis of atherosclerosis. , 1989, Arteriosclerosis.
[62] F. Welt,et al. Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2- macroglobulin inactive complex , 1989, The Journal of cell biology.
[63] R. Alexander,et al. Angiotensin II induces c-fos mRNA in aortic smooth muscle. Role of Ca2+ mobilization and protein kinase C activation. , 1989, The Journal of biological chemistry.
[64] M. Kuro-o,et al. Identification of two types of smooth muscle myosin heavy chain isoforms by cDNA cloning and immunoblot analysis. , 1989, The Journal of biological chemistry.
[65] J J Albers,et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. , 1990, The New England journal of medicine.
[66] J. Thyberg,et al. Regulation of differentiated properties and proliferation of arterial smooth muscle cells. , 1990, Arteriosclerosis.
[67] Harold L. Moses,et al. TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights , 1990, Cell.
[68] U. Steinbrecher,et al. Role of oxidatively modified LDL in atherosclerosis. , 1990, Free radical biology & medicine.
[69] S M Schwartz,et al. Developmental mechanisms underlying pathology of arteries. , 1990, Physiological reviews.
[70] H. Shimano,et al. Human monocyte colony-stimulating factor enhances the clearance of lipoproteins containing apolipoprotein B-100 via both low density lipoprotein receptor-dependent and -independent pathways in rabbits. , 1990, The Journal of biological chemistry.
[71] T. Carew,et al. Macrophages, endothelial cells, and lipoprotein oxidation in the pathogenesis of atherosclerosis. , 1990, Toxicologic pathology.
[72] Atherosclerosis and Hypertension: Mechanisms and Interrelationships , 1990, Journal of cardiovascular pharmacology.
[73] R. Ross,et al. Atherogenesis during low level hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque. , 1990, Arteriosclerosis.
[74] S. Schwartz,et al. Cell proliferation in human coronary arteries. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[75] C. Glass,et al. Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[76] R. Ross,et al. Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. , 1990, Arteriosclerosis.
[77] Timothy A. Springer,et al. Adhesion receptors of the immune system , 1990, Nature.
[78] D. Morel,et al. Activated human monocytes oxidize low-density lipoprotein by a lipoxygenase-dependent pathway. , 1990, Journal of immunology.
[79] C. Heldin,et al. Platelet-derived growth factor: mechanism of action and possible in vivo function. , 1990, Cell regulation.
[80] T. Lüscher. Imbalance of endothelium-derived relaxing and contracting factors. A new concept in hypertension? , 1990, American journal of hypertension.
[81] T. Carlos,et al. Membrane Proteins Involved in Phagocyte Adherence to Endothelium , 1990, Immunological reviews.
[82] A. Gown,et al. Localization of PDGF-B protein in macrophages in all phases of atherogenesis. , 1990, Science.
[83] R. Ross,et al. TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. , 1990, Cell.
[84] D. Harrison,et al. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. , 1990, The Journal of clinical investigation.
[85] M. Yacoub,et al. Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries , 1990, The Lancet.
[86] R. Ross,et al. Atherogenesis during low level hypercholesterolemia in the nonhuman primate. I. Fatty streak formation. , 1990, Arteriosclerosis.
[87] D. Loskutoff,et al. The Fibrinolytic System of the Vessel Wall and Its Role in the Control of Thrombosis , 1990, Annals of the New York Academy of Sciences.
[88] M J Malloy,et al. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. , 1990, JAMA.
[89] M. Daemen,et al. Alpha 1-adrenergic stimulation of platelet-derived growth factor A-chain gene expression in rat aorta. , 1990, The Journal of biological chemistry.
[90] P. Libby,et al. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[91] D. Steinberg. Antioxidants and atherosclerosis. A current assessment. , 1991, Circulation.
[92] M. Reidy,et al. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF , 1991, Science.
[93] S. Parthasarathy,et al. Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts. , 1991, The Journal of clinical investigation.
[94] P. Libby,et al. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[95] G. Hansson,et al. Interferon-gamma inhibits arterial stenosis after injury. , 1991, Circulation.
[96] P. D’Amore,et al. Endothelial cell regulation by transforming growth factor‐beta , 1991, Journal of cellular biochemistry.
[97] D. Loskutoff,et al. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta. , 1991, The Journal of clinical investigation.
[98] M. Klagsbrun,et al. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF , 1991, Science.
[99] M. Reidy,et al. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[100] N. Ringertz,et al. Differences in growth factor response in smooth muscle cells isolated from adult and neonatal rat arteries. , 1991, Differentiation; research in biological diversity.
[101] Jeffrey D. Esko,et al. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.
[102] L. Raij,et al. Role of Endothelium‐Derived Relaxing Factor in Regulation of Vascular Tone and Remodeling Update on Humoral Regulation of Vascular Tone , 1991, Hypertension.
[103] D. Hajjar. Warner-Lambert/Parke-Davis Award Lecture. Viral pathogenesis of atherosclerosis. Impact of molecular mimicry and viral genes. , 1991, The American journal of pathology.
[104] D. Steinberg,et al. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[105] Anita B. Roberts,et al. Peptide Growth Factors and Their Receptors I , 1990, Springer Study Edition.
[106] E. Leonard,et al. Human monocyte chemoattractant protein-1 (MCP-1). , 1990, Immunology today.
[107] G. Bondjers,et al. Immunohistochemical detection of macrophages and T lymphocytes in atherosclerotic lesions of cholesterol-fed rabbits. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[108] M. Cybulsky,et al. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. , 1991, Science.
[109] V. Fuster,et al. A dilemma for the 1990s. Choosing appropriate experimental animal model for the prevention of restenosis. , 1992, Circulation.
[110] V. Ord,et al. Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans. , 1992, The American journal of pathology.
[111] V. Fuster,et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.
[112] J. Isner,et al. Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions. , 1992, The Journal of clinical investigation.
[113] R. Ross,et al. Compartmentalization of PDGF on extracellular binding sites dependent on exon-6-encoded sequences , 1992, The Journal of cell biology.
[114] Michael Simons,et al. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo , 1992, Nature.